Reviews: SGLT Inhibitors: Symptom-Based Drug Discovery and a New Therapeutic Strategy
SGLT2 inhibitor (Luseogliflozin): a new mechanism for treating type 2 diabetes mellitus and therapeutic potential to prevent the progression of diabetic complications